OKTA vs TELA · P/E 84, rev $1.57B vs rev $38.4M
Okta Inc (OKTA) versus Tela Bio Inc (TELA) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Tela Bio Inc (TELA) is a medical devices company listed on NASDAQ.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Latest reported TELA revenue for 2026-06-30 was $38.4M. Net income was -$23.5M. TELA currently screens at market cap $38.5M.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. TELA currently screens at market cap $38.5M.
Not investment advice. Open the OKTA and TELA stock pages for the full models.
Not investment advice.